Congzhu Li

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer

Yihong Huang, Yu Chen, Yan Zhu et al. · Frontiers in Surgery · 2021 · 78 citations · Full text

Medicine, Immunology, Oncology +17

The Nuclear Farnesoid X Receptor Reduces p53 Ubiquitination and Inhibits Cervical Cancer Cell Proliferation

Xiaohua Huang, Bin Wang, Runji Chen et al. · Frontiers in Cell and Developmental Biology · 2021 · 30 citations · Full text

Medicine, Cell Biology, Oncology +14

Efficacy of the induced pluripotent stem cell derived and engineered CD276-targeted CAR-NK cells against human esophageal squamous cell carcinoma

Xiaolan Lin, Tian Guan, Yien Xu et al. · Frontiers in Immunology · 2024 · 14 citations · Full text

Medicine, Immunology, Oncology +17

The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors

Chao Hu, Yinhua Liu, Shan Jiang et al. · Clinical and Translational Medicine · 2020 · 13 citations · Full text

Medicine, Cancer Biology, Oncology +16